PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'TransVIHMI, Institut de Recherche pour le Développement, Institut National de la Santé et de la Recherche Médicale (INSERM), Montpellier University, Montpellier, France.\', \'Département de Virologie, Institut National de Recherche Biomédicale, Kinshasa, Democratic Republic of the Congo.\', \'Département de Biologie Médicale, Université de Kinshasa, Kinshasa, Democratic Republic of the Congo.\', \'Center for Zoonosis Control, Graduate School of Infectious Diseases, Hokkaido University, Sapporo, Japan.\', \'Département d\'Epidémiologie et Statistiques, Ecole de Santé Publique, Université de Kinshasa, Democratic Republic of the Congo.\', \'Département de Nutrition, Ecole de Santé Publique, Université de Kinshasa, Democratic Republic of the Congo.\', \'Epidemiology of Highly Pathogenic Microorganisms Project Group, Robert Koch Institute, Berlin, Germany.\', \'Tropical Infectious Diseases Unit, Department of Public Health, Antwerp, Belgium.\', \'Epigreen, Paris, France.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1093/cid/ciab515
?:hasPublicationType
?:journal
  • Clinical infectious diseases : an official publication of the Infectious Diseases Society of America
is ?:pmid of
?:pmid
?:pmid
  • 34089598
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • High Prevalence of Anti-Severe Acute Respiratory Syndrome Coronavirus 2 (Anti-SARS-CoV-2) Antibodies After the First Wave of Coronavirus Disease 2019 (COVID-19) in Kinshasa, Democratic Republic of the Congo: Results of a Cross-sectional Household-Based Survey.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all